company background image
PHL

Promisia Healthcare NZSE:PHL Stock Report

Last Price

NZ$0.002

Market Cap

NZ$43.6m

7D

0%

1Y

100.0%

Updated

16 Aug, 2022

Data

Company Financials
PHL fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance4/6
Financial Health1/6
Dividends0/6

PHL Stock Overview

Promisia Healthcare Limited engages in the aged care business in New Zealand.

Promisia Healthcare Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Promisia Healthcare
Historical stock prices
Current Share PriceNZ$0.002
52 Week HighNZ$0.002
52 Week LowNZ$0.001
Beta0.98
1 Month Change0%
3 Month Change100.00%
1 Year Change100.00%
3 Year Change0%
5 Year Change-93.55%
Change since IPO-99.69%

Recent News & Updates

Jun 07
Robust Earnings May Not Tell The Whole Story For Promisia Healthcare (NZSE:PHL)

Robust Earnings May Not Tell The Whole Story For Promisia Healthcare (NZSE:PHL)

Promisia Healthcare Limited ( NZSE:PHL ) announced strong profits, but the stock was stagnant. We did some digging, and...

Jul 03
Promisia Healthcare (NZSE:PHL) Is Experiencing Growth In Returns On Capital

Promisia Healthcare (NZSE:PHL) Is Experiencing Growth In Returns On Capital

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Shareholder Returns

PHLNZ Personal ProductsNZ Market
7D0%0.2%0.3%
1Y100.0%-28.2%-9.7%

Return vs Industry: PHL exceeded the NZ Personal Products industry which returned -28.2% over the past year.

Return vs Market: PHL exceeded the NZ Market which returned -9.7% over the past year.

Price Volatility

Is PHL's price volatile compared to industry and market?
PHL volatility
PHL Average Weekly Movementn/a
Personal Products Industry Average Movement11.1%
Market Average Movement4.4%
10% most volatile stocks in NZ Market8.1%
10% least volatile stocks in NZ Market3.0%

Stable Share Price: Insufficient data to determine PHL's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine PHL's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1983335Stuart Bilbroughhttps://www.promisia.co.nz

Promisia Healthcare Limited engages in the aged care business in New Zealand. Its facilities include retirement living in villas and apartments, rest home and hospital care, and dementia care facilities. The company also provides specialized care services, such as palliative, respite, and young disabled care.

Promisia Healthcare Fundamentals Summary

How do Promisia Healthcare's earnings and revenue compare to its market cap?
PHL fundamental statistics
Market CapNZ$43.57m
Earnings (TTM)NZ$2.01m
Revenue (TTM)NZ$19.00m

22.2x

P/E Ratio

2.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PHL income statement (TTM)
RevenueNZ$19.00m
Cost of RevenueNZ$0
Gross ProfitNZ$19.00m
Other ExpensesNZ$16.99m
EarningsNZ$2.01m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.00009
Gross Margin100.00%
Net Profit Margin10.57%
Debt/Equity Ratio92.3%

How did PHL perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is PHL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PHL?

Other financial metrics that can be useful for relative valuation.

PHL key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.1x
Enterprise Value/EBITDA20.4x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does PHL's PE Ratio compare to its peers?

PHL PE Ratio vs Peers
The above table shows the PE ratio for PHL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average24.1x
CVT Comvita
24.8x26.5%NZ$236.4m
LIFD LFTD Partners
9.8xn/aUS$95.2m
GRVI Grove
27.9xn/aUS$89.0m
BILZ Ignite International Brands
33.8xn/aCA$182.7m
PHL Promisia Healthcare
22.2xn/aNZ$43.6m

Price-To-Earnings vs Peers: PHL is good value based on its Price-To-Earnings Ratio (22.2x) compared to the peer average (24.1x).


Price to Earnings Ratio vs Industry

How does PHL's PE Ratio compare vs other companies in the Global Personal Products Industry?

Price-To-Earnings vs Industry: PHL is good value based on its Price-To-Earnings Ratio (22.2x) compared to the Global Personal Products industry average (24.2x)


Price to Earnings Ratio vs Fair Ratio

What is PHL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PHL PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio22.2x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate PHL's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of PHL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PHL (NZ$0) is trading below our estimate of fair value (NZ$0.01)

Significantly Below Fair Value: PHL is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Future Growth

How is Promisia Healthcare forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


32.8%

Forecasted Household industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Promisia Healthcare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

  • Examine whether Promisia Healthcare is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
  • Promisia Healthcare competitive advantages and company strategy can generally be found in its financial reports archived here.

Past Performance

How has Promisia Healthcare performed over the past 5 years?

Past Performance Score

4/6

Past Performance Score 4/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


32.2%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: PHL has a large one-off gain of NZ$721.0K impacting its March 31 2022 financial results.

Growing Profit Margin: PHL's current net profit margins (10.6%) are higher than last year (0.4%).


Past Earnings Growth Analysis

Earnings Trend: PHL has become profitable over the past 5 years, growing earnings by 32.2% per year.

Accelerating Growth: PHL's earnings growth over the past year (9553.8%) exceeds its 5-year average (32.2% per year).

Earnings vs Industry: PHL earnings growth over the past year (9553.8%) exceeded the Personal Products industry 2.7%.


Return on Equity

High ROE: PHL's Return on Equity (10.8%) is considered low.


Discover strong past performing companies

Financial Health

How is Promisia Healthcare's financial position?

Financial Health Score

1/6

Financial Health Score 1/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: PHL's short term assets (NZ$5.1M) do not cover its short term liabilities (NZ$7.7M).

Long Term Liabilities: PHL's short term assets (NZ$5.1M) do not cover its long term liabilities (NZ$25.3M).


Debt to Equity History and Analysis

Debt Level: PHL's net debt to equity ratio (79.4%) is considered high.

Reducing Debt: PHL's debt to equity ratio has increased from 64.2% to 92.3% over the past 5 years.

Debt Coverage: PHL's debt is well covered by operating cash flow (27.9%).

Interest Coverage: PHL's interest payments on its debt are not well covered by EBIT (1.8x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Promisia Healthcare current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate PHL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate PHL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if PHL's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if PHL's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as PHL has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

7.3yrs

Average board tenure


CEO

Stuart Bilbrough

0.25yr

Tenure

Mr. Stuart Bilbrough, BCom, MBA, CA (NZ), served as Chief Executive Officer of Radius Residential Care Limited since June 2020 until November 29, 2021. He is Chief Executive Officer at Promisia Healthcare...


Board Members

Experienced Board: PHL's board of directors are considered experienced (7.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.3%.


Top Shareholders

Company Information

Promisia Healthcare Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Promisia Healthcare Limited
  • Ticker: PHL
  • Exchange: NZSE
  • Founded: 1983
  • Industry: Personal Products
  • Sector: Household
  • Implied Market Cap: NZ$43.570m
  • Shares outstanding: 21.78b
  • Website: https://www.promisia.co.nz

Number of Employees


Location

  • Promisia Healthcare Limited
  • 66 High Street
  • Leeston
  • 7632
  • New Zealand

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/16 00:00
End of Day Share Price2022/08/16 00:00
Earnings2022/03/31
Annual Earnings2022/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.